Biocon Ltd

NeoBiocon partners Novartis to launch diabetes drugs in UAE

Biocon to file for Syngene unit's IPO in two months: Sources

Biocon says to take Syngene unit public

Biocon to buy GE Capital stake in research services arm for $35 mn

Biocon Q1 Net up 9% to Rs 103 crore